Jacobs Levy Equity Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.4M | Sell |
761,184
-1,216,248
| -62% | -$26.2M | 0.06% | 236 |
|
|
2025
Q1 | $32.8M | Buy |
1,977,432
+838,728
| +74% | +$13.9M | 0.13% | 168 |
|
|
2024
Q4 | $20.9M | Sell |
1,138,704
-72,610
| -6% | -$1.33M | 0.07% | 216 |
|
|
2024
Q3 | $18.6M | Sell |
1,211,314
-143,688
| -11% | -$2.21M | 0.07% | 245 |
|
|
2024
Q2 | $22M | Buy |
+1,355,002
| New | +$22M | 0.09% | 203 |
|
|
2024
Q1 | – | Sell |
-105,396
| Closed | -$3.3M | – | 930 |
|
|
2023
Q4 | $3.3M | Sell |
105,396
-1,319,007
| -93% | -$41.3M | 0.02% | 511 |
|
|
2023
Q3 | $29.7M | Sell |
1,424,403
-411,615
| -22% | -$8.58M | 0.18% | 134 |
|
|
2023
Q2 | $44M | Sell |
1,836,018
-46,335
| -2% | -$1.11M | 0.25% | 99 |
|
|
2023
Q1 | $35.4M | Buy |
1,882,353
+243,170
| +15% | +$4.58M | 0.22% | 122 |
|
|
2022
Q4 | $26.1M | Buy |
1,639,183
+552,681
| +51% | +$8.8M | 0.18% | 156 |
|
|
2022
Q3 | $17.8M | Buy |
+1,086,502
| New | +$17.8M | 0.14% | 185 |
|
|
2022
Q2 | – | Sell |
-589,726
| Closed | -$14.3M | – | 985 |
|
|
2022
Q1 | $14.3M | Buy |
589,726
+48,664
| +9% | +$1.18M | 0.1% | 237 |
|
|
2021
Q4 | $12.6M | Buy |
541,062
+30,834
| +6% | +$720K | 0.08% | 263 |
|
|
2021
Q3 | $8.48M | Buy |
+510,228
| New | +$8.48M | 0.06% | 333 |
|
|
2021
Q2 | – | Sell |
-18,845
| Closed | -$486K | – | 1018 |
|
|
2021
Q1 | $486K | Buy |
+18,845
| New | +$486K | ﹤0.01% | 863 |
|